BRIEF-Teva receives FDA approval for VANTRELATM ER
January 18, 2017 at 08:17 AM EST
* Teva receives FDA approval for VANTRELATM ER (hydrocodone bitartrate) extended-release tablets formulated with proprietary abuse deterrence technology Source text for Eikon: Further company coverage: